Understanding Forward-Looking Statements

Shionogi’s statement emphasizes that the information presented⁣ is based on current expectations and assumptions.These are inherently subject⁤ to change due to various factors,potentially leading ⁤to actual outcomes differing materially from those‍ projected. ⁣ Forward-looking statements are not guarantees of future performance.

The company​ specifically highlights risks related ⁣to both the general⁢ economic climate and factors specific to the pharmaceutical industry. These include fluctuations ⁢in economic conditions, interest rates, and currency exchange rates, as well as industry-specific challenges.

Key Risk Areas Identified by Shionogi

Shionogi categorizes risks into several key areas:

• Economic Conditions: General domestic and international economic downturns or instability.
• Product Development: Challenges in completing and potentially discontinuing clinical trials, and the uncertainty of obtaining ‍regulatory‍ approvals for ⁤new products.
• product Safety & Efficacy: Potential claims ​or concerns regarding the safety and effectiveness of Shionogi’s products.
• Technological Advancements: ​The impact⁢ of‍ new technologies that‍ could render existing products obsolete or less‌ competitive.
• Legal & Regulatory: Adverse outcomes‍ in litigation and ⁢changes in domestic and foreign healthcare reforms and regulations.
• Manufacturing & Marketing: ⁣ Difficulties in scaling production‌ to meet demand, supply chain disruptions (lack of raw materials), and increased competition.

Disclaimer of Updates

Shionogi ⁢explicitly states that it does not intend to ​update or revise any forward-looking statements,even if new information becomes⁣ available or if circumstances change.This is‌ standard practice for companies issuing such statements to protect themselves from potential ‌legal liabilities.

Contact Information

For further information, Shionogi directs inquiries to its website contact form: Shionogi Website Inquiry Form.